Literature DB >> 25529976

A template for writing radiotherapy protocols.

Per Nilsson1, Crister Ceberg, Elisabeth Kjellén, Giovanna Gagliardi, Klas Blomgren, Sten Nilsson, Mikael Johansson, Bengt Glimelius.   

Abstract

BACKGROUND: Well-specified and unambiguous treatment protocols are essential both for current practice and for the future development of radiation therapy. In order to provide assistance for writing good protocols, irrespective of treatment intention and complexity, up-to-date guidelines are highly desirable.
METHODS: We have analysed the radiotherapy work-flow, including clinical and physical aspects, such as preparatory imaging, treatment planning, delivery and evaluation, with the aim to outline a consistent framework covering the entire radiotherapy process.
RESULTS: Based on the analysis, a recipe-style template for specifying the description of the radiotherapy process has been designed. The template is written in a general format, which allows for modified phrasing, and should be customised for the specific clinical situation and diagnosis, as well as facility resources.
CONCLUSIONS: The template can be used as a tool to ensure a consistent and comprehensive description of the radiotherapy section of clinical guidelines, care programmes and clinical trial protocols.

Mesh:

Year:  2014        PMID: 25529976     DOI: 10.3109/0284186X.2014.981285

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  2 in total

1.  Quality of reporting on thoracic radiotherapy technique in prospective lung cancer trials: A systematic review.

Authors:  Yu Yang Soon; Desiree Chen; Teng Hwee Tan; Jeremy Chee Seong Tey
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

2.  Quality of reporting of cranial irradiation techniques in randomized controlled trials of primary brain tumors: A systematic review.

Authors:  Teng Hwee Tan; Desiree Chen; Yu Yang Soon; Jeremy Chee Seong Tey
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.